Eledon Pharmaceuticals

About:

Eledon Pharmaceuticals is a biotechnology company developing treatments for people undergoing organ or cellular transplantation.

Website: https://eledon.com/

Twitter/X: eledon_pharma

Top Investors: Blue Owl, OrbiMed, RA Capital Management, Fidelity, Cormorant Asset Management

Description:

Eledon Pharmaceuticals is a clinical-stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation and for people with autoimmune and neurodegenerative diseases.

Total Funding Amount:

$368M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Irvine, California, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)eledon.com

Founders:

Joseph A. Yanchik III

Number of Employees:

11-50

Last Funding Date:

2024-10-29

IPO Status:

Public

© 2025 bioDAO.ai